THERAPY FOR ADVANCED COLORECTAL-CANCER WITH A COMBINATION OF 5-FU AND ANGUIDINE - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：0
作者：
GOODWIN, W
STEPHENS, R
MCCRACKEN, JD
GROPPE, C
机构：
[1] USAF,MED CTR,DEPT HEMATOL ONCOL,LACKLAND AFB,TX 78236
[2] UNIV KANSAS,MED CTR,DIV ONCOL,KANSAS CITY,KS 66103
[3] BROOKE ARMY MED CTR,DIV HEMATOL ONCOL,FT SAM HOUSTON,TX 78234
[4] CLEVELAND CLIN EDUC FDN,DEPT HEMATOL & MED ONCOL,CLEVELAND,OH 44106
来源：
CANCER TREATMENT REPORTS | 1981年 / 65卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [41] RUBIDAZONE IN THE TREATMENT OF ADVANCED CHILDHOOD LEUKEMIA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    RAGAB, A
    FRANKEL, L
    VIETTI, TJ
    FALLETTA, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 384 - 384
  • [42] COMBINATION CHEMOTHERAPY OF CISPLATIN AND 5-FU IN ADVANCED COLORECTAL-CARCINOMA
    DY, C
    GIL, A
    ALGARRA, SM
    APARICIO, LA
    CALVO, F
    HERRANZ, P
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 465 - 468
  • [43] PHASE-II EVALUATION OF ANGUIDINE IN CENTRAL NERVOUS-SYSTEM TUMORS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    GOODWIN, JW
    BOTTOMLEY, RH
    VAUGHN, CB
    FRANK, J
    PUGH, RP
    CANCER TREATMENT REPORTS, 1983, 67 (03): : 285 - 286
  • [44] CAN FOLATES IMPROVE THE EFFICACY OF 5-FU IN A POLYCHEMOTHERAPY SCHEDULE - A NEW TREATMENT FOR ADVANCED COLORECTAL-CANCER
    NIGRA, E
    LACIURA, P
    COMANDONE, A
    LAGROTTA, G
    LERIA, G
    GRECCHI, GL
    CALCIATI, A
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 135 - 135
  • [45] Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study
    Presant, CA
    Jacobson, J
    Wolf, W
    Waluch, V
    Weitz, IC
    Macdonald, JS
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (04) : 369 - 376
  • [46] Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study
    Cary A. Presant
    Joth Jacobson
    Walter Wolf
    Victor Waluch
    Ilene C. Weitz
    John S. Macdonald
    Investigational New Drugs, 2002, 20 : 369 - 376
  • [47] Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?
    Twelves, C
    ONCOLOGY-NEW YORK, 2002, 16 (12): : 23 - 26
  • [48] RANDOMIZED CLINICAL-TRIAL WITH A WEEKLY REGIMEN OF 5-FU VS 5-FU + INTERMEDIATE-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    MARTONI, A
    CRICCA, A
    GUARALDI, M
    COVIZZI, M
    FARRIS, A
    PANNUTI, F
    ANNALS OF ONCOLOGY, 1992, 3 (01) : 87 - 88
  • [49] BAKER ANTIFOL (BAF) IN COMBINATION WITH METHYL CCNU AND 5-FLUOROURACIL (5-FU) FOR THE TREATMENT OF METASTATIC COLORECTAL-CANCER
    SHAW, MT
    HEILBRUN, LK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 300 - 300
  • [50] NONLINEAR PHARMACOKINETIC CHARACTERISTICS OF 5-FLUOROURACIL (5-FU) IN COLORECTAL-CANCER PATIENTS
    SCHAAF, LJ
    DOBBS, BR
    EDWARDS, IR
    PERRIER, DG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (04) : 411 - 418
12345